Alzamend Neuro Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Alzamend Neuro Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Alzamend Neuro Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Alzamend Neuro Inc. is ALZN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Alzamend Neuro Inc. has its primary listing on NASDAQ (Small cap). You can trade Alzamend Neuro Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Alzamend Neuro Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Alzamend Neuro Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Alzamend Neuro Inc..